Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Lipid Absorption01:24

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Porphyromonas gingivalis infection alters Nrf2-phase II enzymes and nitric oxide in primary human aortic endothelial cells.

Journal of periodontology·2020
Same author

Transport of Apolipoprotein B-Containing Lipoproteins through Endothelial Cells Is Associated with Apolipoprotein E-Carrying HDL-Like Particle Formation.

International journal of molecular sciences·2018
Same author

Overexpression of Catalase Enhances Benzo(a)pyrene Detoxification in Endothelial Microsomes.

PloS one·2016
Same author

Akt isoform-dependent regulation of ATP-Binding cassette A1 expression by apolipoprotein E.

Biochemical and biophysical research communications·2016
Same author

Increase in Blood Glutathione and Erythrocyte Proteins Related to Glutathione Generation, Reduction and Utilization in African-American Old Women with Diabetes.

Journal of science, technology and environment·2016
Same author

A Subregion of Reelin Suppresses Lipoprotein-Induced Cholesterol Accumulation in Macrophages.

PloS one·2015

Related Experiment Video

Updated: May 15, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

Cholecystokinin elevates mouse plasma lipids.

Lichun Zhou1, Hong Yang, Xinghua Lin

  • 1Department of Physiology, Meharry Medical College, Nashville, TN, USA.

Plos One
|January 10, 2013
PubMed
Summary

Cholecystokinin (CCK) significantly increases plasma cholesterol and triglycerides in mice by promoting biliary lipid reabsorption from the intestine. This peptide hormone

Area of Science:

  • Biochemistry
  • Endocrinology
  • Gastroenterology

Background:

  • Cholecystokinin (CCK) is a peptide hormone regulating digestion and fat absorption.
  • Bile acid and cholesterol excretion normally eliminates cholesterol, but CCK's role in plasma lipid levels is unclear.

Purpose of the Study:

  • To investigate the effect of CCK on plasma cholesterol and triglyceride levels in mice.
  • To elucidate the mechanisms underlying CCK-induced hyperlipidemia.

Main Methods:

  • Intravenous injection of a CCK analog ([Thr28, Nle31]-CCK) in low-density lipoprotein receptor knockout (LDLR(-/-)) and wild-type mice.
  • Analysis of plasma lipid and apolipoprotein levels.
  • Intervention with bile duct ligation, CCK receptor antagonist (proglumide), and NPC1L1 inhibitor (ezetimibe).

More Related Videos

The Isolation of Flowing Mesenteric Lymph in Mice to Quantify In Vivo Kinetics of Dietary Lipid Absorption and Chylomicron Secretion
06:14

The Isolation of Flowing Mesenteric Lymph in Mice to Quantify In Vivo Kinetics of Dietary Lipid Absorption and Chylomicron Secretion

Published on: November 30, 2022

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

Related Experiment Videos

Last Updated: May 15, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

The Isolation of Flowing Mesenteric Lymph in Mice to Quantify In Vivo Kinetics of Dietary Lipid Absorption and Chylomicron Secretion
06:14

The Isolation of Flowing Mesenteric Lymph in Mice to Quantify In Vivo Kinetics of Dietary Lipid Absorption and Chylomicron Secretion

Published on: November 30, 2022

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

Main Results:

  • CCK significantly increased plasma triglycerides and cholesterol in LDLR(-/-) mice.
  • CCK caused smaller, non-significant increases in wild-type mice.
  • CCK-induced hypercholesterolemia involved alterations in VLDL, LDL, and HDL, with increased apoB48, apoB100, apoE, and apoAI.
  • Bile duct ligation, proglumide, and ezetimibe treatments attenuated the hyperlipidemic effect of CCK.

Conclusions:

  • CCK administration increases plasma cholesterol and triglycerides.
  • These effects are mediated by enhanced reabsorption of biliary lipids from the intestine.
  • CCK plays a role in regulating lipid metabolism beyond its known digestive functions.